The purpose of this study was to evaluate the diagnostic performance, impact on patient disease management, and therapy efficacy prediction of PET/CT using a PSMA ligand radiolabelled with gallium-68, the [68Ga]Ga-PSMA-11, on the restaging of PCa patients presenting with BCR. Here, BCR is linked to posterior cortical atrophy.